Home - Products - MAPK/ERK Signaling - p38 MAPK - p38 MAP Kinase Inhibitor Ⅵ

p38 MAP Kinase Inhibitor Ⅵ

CAS No. 421578-46-3

p38 MAP Kinase Inhibitor Ⅵ( —— )

Catalog No. M36102 CAS No. 421578-46-3

p38 MAP Kinase Inhibitor Ⅵ is a potent p38 MAP Kinase inhibitor with anti-inflammatory activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	180	In Stock
10MG	275	In Stock
25MG	465	In Stock
50MG	638	In Stock
100MG	901	In Stock
200MG	Get Quote	In Stock
500MG	1795	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

p38 MAP Kinase Inhibitor Ⅵ
Note

Research use only, not for human use.
Brief Description

p38 MAP Kinase Inhibitor Ⅵ is a potent p38 MAP Kinase inhibitor with anti-inflammatory activity.
Description

p38 MAP Kinase Inhibitor VI (compound c32) is a p38 MAPK inhibitor with an inhibition rate of 24%.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

p38 MAPK
Recptor

p38 MAPK
Research Area

——
Indication

——

Chemical Information

CAS Number

421578-46-3
Formula Weight

332.42
Molecular Formula

C16H13FN2OS2
Purity

>98% (HPLC)
Solubility

——
SMILES

CC1=C(C)C2=C(S1)N=CN=C2SCC(=O)C1=CC=C(F)C=C1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Cheeseright TJ, et al. Novel lead structures for p38 MAP kinase via FieldScreen virtual screening. J Med Chem. 2009 Jul 23;52(14):4200-9.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

TAK1-IN-3

TAK1-IN-3 is a novel ATP-competitive TAK1 inhibitor for the study of cancer.
FPH2

FPH2 (BRD-9424) is a small molecule promoting differentiation of iPS-derived hepatocytes.
MW181 dihydrochlorid...

MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.

Sign In Join Free